Related Experiment Videos
[A study of platelet activation following coronary angioplasty. Effect on acute occlusion and restenosis]
C Durrieu-Jaïs1, L Macchi, C Bihour
1Unité de soins intensifs, Hôpital cardiologique, Pessac.
Insights
Platelet activation was observed 24 and 48 hours after coronary angioplasty, despite aspirin treatment. This platelet activation, while not predicting restenosis, may contribute to acute occlusion via thrombosis.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Immunology
Background:
- Platelet activation is crucial in thrombosis and cardiovascular events.
- Monoclonal antibodies enable detection of activated platelets via cytometry.
- Coronary angioplasty is a common procedure with potential thrombotic complications.
Purpose of the Study:
- To investigate platelet activation in patients undergoing coronary angioplasty.
- To assess the temporal profile of platelet activation post-procedure.
- To correlate platelet activation with clinical outcomes like restenosis.
Main Methods:
- Blood samples collected from 35 patients at multiple time points before and after coronary angioplasty.
- Flow cytometry used with anti-platelet antibodies to detect activated platelets.
- Coronary angiography performed at 6 months to assess vessel diameter and restenosis.
Main Results:
- Significant platelet activation observed 24 and 48 hours post-angioplasty, not earlier.
- A correlation found between pre-angioplasty and 24-hour post-angioplasty platelet activation levels.
- No statistically significant correlation between post-angioplasty platelet activation and restenosis progression.
Conclusions:
- Platelet activation occurs secondary to coronary angioplasty, even with aspirin therapy.
- Activated platelets may contribute to acute thrombotic occlusion.
- Activated platelet detection was not predictive of 6-month restenosis in this study.
Abstract:
The development of monoclonal anti-platelet antibodies to activation-dependent epitopes has made possible the study of the appearance of activated platelets in the blood by cytometry. This was undertaken in 35 patients undergoing coronary angioplasty. Blood was sampled through the femoral venous catheter introducer before the procedure, at 3 minutes and 3, 24 and 48 hours after angioplasty. Systematic coronary angiography was performed at about 6 months and vessel diameters were quantified by a digitised technique. In general, platelet activation was not observed before angioplasty or in the first hours following the procedure. On the other hand, a significant number of activated platelets was observed secondarily : 7 +/- 7.3% at the 24th hour and 6.8 +/- 5.9% at the 48th hour. There was a significant correlation between the level of platelet activation before angioplasty and that at the 24th hour (r = 0.52, p = 0.01). There was a tendency to more activated circulating platelets before and 24 hours after angioplasty in patients with acute occlusion. The correlation coefficient between the level of activated platelets 24 hours after angioplasty and progression of stenosis at 6 months was not statistically significant (r = 0.29). Therefore, the authors demonstrated platelet activation, which was sometimes considerable, inconstantly in circulating venous blood of patients with angina 24 hours after coronary angioplasty despite treatment with aspirin. Activated platelets may play a role in constituting acute occlusion by thrombosis but their detection was not predictive of restenosis.